With subcutaneous injection, these central and peripheral effects occur simultaneously because the peptide distributes throughout the body via systemic circulation
If youve been benefiting from supplementation, stopping may reduce your antioxidant reserves
What if I have questions about my benefits

GHK-Cu published research history: - First isolated and characterized: 1973 - Continuous peer-reviewed publication: 50+ years - Published research covering: wound healing, skin biology, COPD, oxidative stress, bone, skeletal muscle, gastrointestinal, neurological, gene expression, aging - Mechanistic characterization: Multiple pathways identified, SIRT1 direct binding confirmed in 2025 - Cell and animal model validation: Extensive across multiple tissue types and species Matrixyl 3000 (palmitoyl tripeptide-1 + palmitoyl tetrapeptide-7) research: - Commercial introduction: Early 2000s - Research base: Primarily cosmetic science and dermatology literature - Mechanistic characterization: Primarily focused on TGF-beta receptor and IL-6 pathways - Depth: Narrower tissue focus, smaller body of published mechanistic research For researchers who need a compound with extensive published mechanistic context, detailed gene expression data, or research across multiple tissue types, GHK-Cu's research depth is substantially greater

Pharmacol Res 220:107927 Jun L, Tao YX, Geetha T, Babu JR (2024) Mitochondrial adaptation in skeletal muscle: impact of Obesity, caloric Restriction, and dietary compounds
Patients often report losing 24 pounds per week during this phase, with improved energy levels and reduced food obsession